LIFESIGN STAPH LATEX 50051

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a 08 report with the FDA on 2010-01-15 for LIFESIGN STAPH LATEX 50051 manufactured by Nerl Diagnostics Llc..

Event Text Entries

[20996448] On december 15, 2009, it was confirmed that the staph latex reagent was not sufficiently reactive with a known positive control. The staph latex kit is a latex agglutination kit in which the reagent should agglutinate when tested with a known positive control organism (b)(6). When the kit in question was tested with the positive control weakened agglutination was observed.
Patient Sequence No: 1, Text Type: D, B5


[21199767] In response to the receipt of one complaint for this kit lot, and for two other kit lots noted in mrn 1215667-2010-00001, we conducted an investigation. We repeated quality control release testing on retention kits. Our testing indicated reduced reactivity (out of spec) of the latex reagent in the presence of the recommended positive control. Based on these results, we conducted a risk assessment. A decision was made to recall this lot of product which was shipped to one distributor. We are working with that distributor to ensure that all end users are notified of the recall. A sample letter to the distributor is attached. The bulk lot of staph latex reagent used to manufacture this kit lot was also used for another device. Please refer to mfr report number 1215667-2010-00001. In addition, to ensure that this product malfunction does not recur, the following measures were taken. The sop for stock culture maintenance (b)(4) has been updated to include the organisms utilized for the qc bulk and release testing for the staph latex kit. Appropriate qc personnel have been trained to the new revision (b)(4). Eval summary: nerl retention sample kit was tested according to qc release testing procedure. During the complaint investigation for lifesign staph latex lot # 1009029, the following results were obtained.
Patient Sequence No: 1, Text Type: N, H10


MAUDE Entry Details

Report Number1215667-2010-00002
MDR Report Key1588044
Report Source08
Date Received2010-01-15
Date of Report2010-01-15
Date of Event2009-12-15
Date Mfgr Received2009-12-15
Device Manufacturer Date2009-09-01
Date Added to Maude2010-09-20
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Health Professional3
Initial Report to FDA3
Report to FDA0
Event Location0
Manufacturer ContactTINA LOMBARI
Manufacturer Street14 ALMEIDA AVE.
Manufacturer CityEAST PROVIDENCE RI 02914
Manufacturer CountryUS
Manufacturer Postal02914
Manufacturer Phone4018242046
Single Use3
Remedial ActionRL
Previous Use Code3
Event Type3
Type of Report3

Device Details

Brand NameLIFESIGN STAPH LATEX
Product CodeJWX
Date Received2010-01-15
Catalog Number50051
Lot Number1009029
Device Expiration Date2012-06-01
OperatorOTHER
Device AvailabilityN
Device AgeDA
Device Eval'ed by MfgrY
Device Sequence No1
Device Event Key0
ManufacturerNERL DIAGNOSTICS LLC.
Manufacturer Address14 ALMEIDA AVE. EAST PROVIDENCE RI 02914 US 02914


Patients

Patient NumberTreatmentOutcomeDate
101. Other 2010-01-15

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.